Gerber F, Fournier M, Pariente R
Rev Mal Respir. 1985;2(5):313-7.
This prospective study was done in 8 patients with chronic asthma, hospitalised for an exacerbation of their illness without any evidence of airway infection. The intention was to measure both qualitatively and quantitatively the impact of high dosage glucocorticoids on the inflammatory changes of the bronchial mucus in such patients. Biopsies of the proximal bronchi by fibreoscopy were taken before and after 6 to 9 days of Prednisolone (0.5-0.75 mg/kg per day), this treatment led to a relative rise in the FEV1 (VEMS) of at least 15%. These biopsies were fixed in Bouin and Paraffin, and the sections simultaneously processed for qualitative identification (histochemical and immuno-peroxidasic) of cells infiltrating the bronchial mucosa and for a count of these cells in a pre-determined sub-epithelial zone. It was noted: In all patients at the entry to the study: an essentially lympho-monocytic cellular infiltrate of the bronchial mucosa, a virtual absence of neutrophils, and various abnormalities of the surface epithelium. After 6 to 9 days of steroids there was a persistence of epithelial lesions and in 6 out of 8 patients a statistically significant fall in the density of the inflammatory infiltrate. In 75% patients suffering from exacerbations of chronic asthma, the improvement in the ventilatory function with dosage corticotherapy was accompanied by a fall in the level of inflammatory infiltrate in the proximal bronchi.
这项前瞻性研究针对8例慢性哮喘患者开展,这些患者因病情加重入院,且无任何气道感染迹象。目的是定性和定量地测量高剂量糖皮质激素对此类患者支气管黏液炎症变化的影响。在给予泼尼松龙(每天0.5 - 0.75毫克/千克)治疗6至9天前后,通过纤维支气管镜对近端支气管进行活检,该治疗使第一秒用力呼气容积(VEMS)相对升高至少15%。这些活检标本用布因氏液和石蜡固定,切片同时进行处理,以对浸润支气管黏膜的细胞进行定性鉴定(组织化学和免疫过氧化物酶法),并在预先确定的上皮下区域对这些细胞进行计数。结果发现:在研究开始时,所有患者的支气管黏膜均主要为淋巴细胞 - 单核细胞浸润,几乎没有中性粒细胞,且表面上皮存在各种异常。使用类固醇治疗6至9天后,上皮病变持续存在,8例患者中有6例炎症浸润密度出现统计学显著下降。在75%的慢性哮喘加重患者中,糖皮质激素治疗剂量增加时通气功能改善,同时近端支气管炎症浸润水平下降。